Heart Disease News and Research

Latest Heart Disease News and Research

Thrombolytic therapy can reduce stroke disability if given within the first few hours

Routing stroke patients directly to designated stroke centres - instead of taking them to the nearest hospital - dramatically increased access to a key clot-busting drug that can reduce stroke disability if given within the first few hours of symptoms, researchers report in Stroke: Journal of the American Heart Association.

30 Oct 2009

Study shows how differing Asian cultures and attitudes impact cancer screening rates

The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander."

30 Oct 2009

Majority of consumers say food scoring system would influence their purchasing decisions

Grocery shoppers in a new study report that a one to 100-point food rating system would help them choose what goes into their carts.

30 Oct 2009

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

TomoTherapy Incorporated announced today that several clinical presentations at the American Society for Radiation Oncology's 51st ASTRO Annual Meeting -- November 1-5, 2009 in Chicago -- will showcase the use of the TomoTherapy® radiation therapy platform as a vital component in the combined modality approach to treating cancer.

30 Oct 2009

VIVUS presents additional data on Qnexa Phase 3 trials

VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.

30 Oct 2009

NIH launches randomized trail to determine whether lower BP goal cuts the risk of heart and kidney diseases

The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.

30 Oct 2009

Aerobics and resistance training exercise prevent visceral fat gain

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

30 Oct 2009

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY’s midkine patent portfolio for the development of novel lung cancer diagnostics.

30 Oct 2009

Vitamin D deficiency may account for increased risk of end-stage renal disease in African Americans

Low levels of vitamin D may account for nearly 60 percent of the elevated risk of end-stage renal disease (ESRD) in African Americans, according to a report in the December Journal of the American Society of Nephrology (JASN).

30 Oct 2009

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.

30 Oct 2009

Also in Global Health news: Sudan food aid; Congolese refugees; Ntds in U.S.

David Deng Athorbei, South Sudan's finance minister, "said he was trying to track down hundreds of millions of dollars worth of missing grain deliveries, at the heart of what could be a massive case of mismanagement or corruption," Reuters reports.

29 Oct 2009

CIRM awards Cedars-Sinai Heart Institute $5.5 million grant for development of cardiac stem cell therapies

A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marb-n, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.

29 Oct 2009

Bolton Medical reports first U.S. trial of its Relay Plus System for endovascular stent-graft procedures

Bolton Medical announced today the first use of its new Relay Plus System in the U.S. Relay Clinical Trial. The case took place at the University of Pennsylvania Medical Center in Philadelphia, PA.

29 Oct 2009

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

The management of dyslipidemia continues to evolve and despite improvements in recurrent cardiovascular events and a decrease in cardiac mortality, cardiovascular disease (CVD) still represents the major burden of disease in this country.

29 Oct 2009

CryoLife reports a net income of $1.9 million for the third quarter of 2009

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the third quarter of 2009 increased 5 percent to a quarterly record of $28.2 million compared to $26.8 million for the third quarter of 2008.

29 Oct 2009

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the “American Recovery and Reinvestment Act of 2009”. The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.

29 Oct 2009

NMT Medical reports financial results for third-quarter 2009; narrows net loss to $0.22 per share

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.

29 Oct 2009

New herbal medicinal product for reducing mental and physical stress

Marketed under the trade name Vitango® and now available from pharmacies, the product is a special extract of a highly resilient plant called Golden Root (Rhodiola rosea) that grows in the freezing conditions of Northern Europe and Asia's mountain peaks.

29 Oct 2009

WaveMark CIMS implemented at St. Joseph’s Hospital

WaveMark, Inc., a leading provider of real-time inventory management (RTIM) solutions for high value medical products, and St. Joseph’s Hospital of Atlanta, GA today announced the use of WaveMark’s hospital inventory management solution, WaveMark CIMS™, by St. Joseph’s Hospital to manage its high value, specialty inventory. St. Joseph’s will use WaveMark’s point of use RTIM technology to track physician preference items in its Cardiac Cath and Electrophysiology (EP) labs.

29 Oct 2009

Unaudited consolidated financial results for the third-quarter reported by AMAG Pharmaceuticals

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009.

29 Oct 2009

Heart Disease News and Research

Latest Heart Disease News and Research

Thrombolytic therapy can reduce stroke disability if given within the first few hours

Study shows how differing Asian cultures and attitudes impact cancer screening rates

Majority of consumers say food scoring system would influence their purchasing decisions

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

VIVUS presents additional data on Qnexa Phase 3 trials

NIH launches randomized trail to determine whether lower BP goal cuts the risk of heart and kidney diseases

Aerobics and resistance training exercise prevent visceral fat gain

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

Vitamin D deficiency may account for increased risk of end-stage renal disease in African Americans

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Also in Global Health news: Sudan food aid; Congolese refugees; Ntds in U.S.

CIRM awards Cedars-Sinai Heart Institute $5.5 million grant for development of cardiac stem cell therapies

Bolton Medical reports first U.S. trial of its Relay Plus System for endovascular stent-graft procedures

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

CryoLife reports a net income of $1.9 million for the third quarter of 2009

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

NMT Medical reports financial results for third-quarter 2009; narrows net loss to $0.22 per share

New herbal medicinal product for reducing mental and physical stress

WaveMark CIMS implemented at St. Joseph’s Hospital

Unaudited consolidated financial results for the third-quarter reported by AMAG Pharmaceuticals

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Heart Disease News and Research

Latest Heart Disease News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in